BACKGROUND AND OBJECTIVES: Assessments of iron stores by serum iron saturation ratio (ISAT) and ferritin are used to direct anemia therapy in chronic kidney disease (CKD) and are associated with clinical outcomes in patients on dialysis. The association of ISAT and ferritin with outcomes in patients with nondialysis-dependent CKD (NDD-CKD) has not been studied. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: All-cause mortality and progression of CKD [slopes of estimated GFR (eGFR)] were examined in 453 men with NDD-CKD. Mortality and the composite of mortality and ESRD were studied in Cox models. Slopes of eGFR were examined in mixed-effects models. RESULTS: Lower ISAT was associated with higher mortality; adjusted hazard ratio [95% confidence interval (CI)] with ISAT of <12%, 13 to 17%, and >23% versus 18 to 23%; 1.40 (0.99 to 1.98), 1.20 (0.82 to 1.76), and 0.97 (0.67 to 1.41), P = 0.025 for trend. ISAT was also associated with steeper slopes of eGFR (one log-unit higher ISAT associated with a slope of -0.89 ml/min/1.73 m(2) /yr (95% CI: -1.75, -0.02, P = 0.044). Serum ferritin level showed no significant association with outcomes overall, but a trend for higher mortality was observed in patients with a serum ferritin level >250 ng/ml. CONCLUSIONS: Higher ISAT is associated with lower mortality and with more progressive CKD. Clinical trials are needed to examine if correction of low iron levels can improve mortality without affecting kidney function in NDD-CKD.
BACKGROUND AND OBJECTIVES: Assessments of iron stores by serum iron saturation ratio (ISAT) and ferritin are used to direct anemia therapy in chronic kidney disease (CKD) and are associated with clinical outcomes in patients on dialysis. The association of ISAT and ferritin with outcomes in patients with nondialysis-dependent CKD (NDD-CKD) has not been studied. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: All-cause mortality and progression of CKD [slopes of estimated GFR (eGFR)] were examined in 453 men with NDD-CKD. Mortality and the composite of mortality and ESRD were studied in Cox models. Slopes of eGFR were examined in mixed-effects models. RESULTS: Lower ISAT was associated with higher mortality; adjusted hazard ratio [95% confidence interval (CI)] with ISAT of <12%, 13 to 17%, and >23% versus 18 to 23%; 1.40 (0.99 to 1.98), 1.20 (0.82 to 1.76), and 0.97 (0.67 to 1.41), P = 0.025 for trend. ISAT was also associated with steeper slopes of eGFR (one log-unit higher ISAT associated with a slope of -0.89 ml/min/1.73 m(2) /yr (95% CI: -1.75, -0.02, P = 0.044). Serum ferritin level showed no significant association with outcomes overall, but a trend for higher mortality was observed in patients with a serum ferritin level >250 ng/ml. CONCLUSIONS: Higher ISAT is associated with lower mortality and with more progressive CKD. Clinical trials are needed to examine if correction of low iron levels can improve mortality without affecting kidney function in NDD-CKD.
Authors: N Tessitore; G P Solero; G Lippi; A Bassi; G B Faccini; V Bedogna; L Gammaro; G Brocco; G Restivo; P Bernich; A Lupo; G Maschio Journal: Nephrol Dial Transplant Date: 2001-07 Impact factor: 5.992
Authors: Kamyar Kalantar-Zadeh; Charles J McAllister; Robert S Lehn; Enwu Liu; Joel D Kopple Journal: Am J Kidney Dis Date: 2004-04 Impact factor: 8.860
Authors: Monique E Cho; Jared L Hansen; Brian C Sauer; Alfred K Cheung; Adhish Agarwal; Tom Greene Journal: Clin J Am Soc Nephrol Date: 2021-03-29 Impact factor: 8.237
Authors: Soon Mi Hur; Hye Young Ju; Moo Yong Park; Soo Jeong Choi; Jin Kuk Kim; Seung Duk Hwang Journal: Korean J Intern Med Date: 2014-06-27 Impact factor: 2.884
Authors: Maciej Banach; Wilbert S Aronow; Maria-Corina Serban; Jacek Rysz; Luminita Voroneanu; Adrian Covic Journal: Lipids Health Dis Date: 2015-12-30 Impact factor: 3.876
Authors: Shilpa Sharma; Ronit Katz; Alexander L Bullen; Paulo H M Chaves; Peter W de Leeuw; Abraham A Kroon; Alfons J H M Houben; Michael G Shlipak; Joachim H Ix Journal: J Clin Endocrinol Metab Date: 2020-12-01 Impact factor: 5.958
Authors: Murilo Guedes; Daniel G Muenz; Jarcy Zee; Brian Bieber; Benedicte Stengel; Ziad A Massy; Nicolas Mansencal; Michelle M Y Wong; David M Charytan; Helmut Reichel; Sandra Waechter; Ronald L Pisoni; Bruce M Robinson; Roberto Pecoits-Filho Journal: J Am Soc Nephrol Date: 2021-07-08 Impact factor: 14.978
Authors: Shilpa Sharma; Ronit Katz; Ruth F Dubin; David A Drew; Orlando M Gutierrez; Michael G Shlipak; Mark J Sarnak; Joachim H Ix Journal: J Am Geriatr Soc Date: 2020-11-10 Impact factor: 7.538